Molecular mechanisms of mucocutaneous immunity against Candida and Staphylococcus species.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 23040277.
- Also identified by DOI 10.1016/j.jaci.2012.09.011 and PMC identifier 3703675.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Signal transducer and activator of transcription (STAT) proteins are key components of the innate and adaptive immune responses to pathogenic microorganisms. Recent research on primary immunodeficiency disorders and the identification of patients carrying germline mutations in STAT1, STAT3, and STAT5B have highlighted the role of human STATs in host defense against various viruses, bacteria, and fungi. Mutations in STAT1 and STAT3 disrupt various cytokine pathways that control mucocutaneous immunity against Candida species, especially Candida albicans, and Staphylococcus species, especially Staphylococcus aureus. Here we consider inborn errors of immunity arising from mutations in either STAT1 or STAT3 that affect mucocutaneous immunity to Candida and Staphylococcus species.
Medical subject headings
- Candida
- Candidiasis
- Immunologic Deficiency Syndromes
- Staphylococcal Infections
- Staphylococcus